drugset / Trial / NCT02172261
Relative Bioavailability of BI 10773 and Glimepiride in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The objective was to investigate whether there was a drug-drug interaction between BI 10773 and glimepiride when co-administered. Therefore, the relative bioavailabilities of BI 10773 and glimepiride were determined when both drugs were given in combination compared to multiple oral doses of BI 10773 once daily alone and a single oral dose of glimepiride given alone.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 50 mg | Oral |
| Subject | Glimepiride | Small molecule | 1 mg | Oral |
Indications
No indication recorded.